APA (7th ed.) Citation

DM, B., L, N., M, G., J, M., N, B., L, H., . . . RJM, B. (2024). Drug-Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians. Clinical pharmacokinetics, 63(11), 1529. https://doi.org/10.1007/s40262-024-01437-5

Chicago Style (17th ed.) Citation

DM, Burger, Nijboer L, Ghobreyal M, Maertens J, Blijlevens N, Hilbrands L, Baas MC, Ljungman P, and Brüggemann RJM. "Drug-Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians." Clinical Pharmacokinetics 63, no. 11 (2024): 1529. https://doi.org/10.1007/s40262-024-01437-5.

MLA (9th ed.) Citation

DM, Burger, et al. "Drug-Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians." Clinical Pharmacokinetics, vol. 63, no. 11, 2024, p. 1529, https://doi.org/10.1007/s40262-024-01437-5.